The problem
New artemisinin-based combination therapies (ACTs) were introduced in response to decreasing effectiveness of previous antimalarial drugs. However, their widespread use was hindered due to their relatively high cost compared to older treatments and limited funding available to malaria-endemic countries.
Download the project evaluation
Our response
This project increased the availability of safe, effective and fast-acting antimalaria treatments, delivering more than 37 million ACTs to nine malaria-endemic countries: Cambodia, Ethiopia, Ghana, Indonesia, Madagascar, Mozambique, South Sudan, Sudan and Zambia. Procurement and delivery times were significantly reduced and no countries participating in the project suffered ACT stock-outs. Our investment led to a quick and steady supply of effective malaria drugs at affordable prices. This scale up in use helped drive down the number of malaria deaths.
